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Glenn F. Browning2 and Liza Rosenbaum Nielsen1
Abstract
Background: Inexpensive and convenient diagnostic tests for use in clinical work and for the surveillance of
infection with Mycoplasma bovis are in demand. The objective of this longitudinal field study was to gain
knowledge about the dynamics of antibodies against M. bovis in sera from naturally exposed calves with and
without different clinical signs, measured by two different ELISA tests.
Results: A total of 83 calves were subject to between one and five blood samples and clinical examinations using a
standard protocol during five herd visits to each of four outbreak dairy herds. The blood samples were analysed for
the presence of antibodies against M. bovis using the commercial IgG ELISA test BioX K302 (BioX) and an in-house
indirect IgG ELISA test (MilA ELISA).
Linear mixed models were used to describe and compare the antibody dynamics as measured by the two tests in
relation to the disease status and age of the animals.
The BioX ELISA response was below the recommended cut-off (37 ODC%) for the entire study period in many of
the calves. The estimated mean ODC% increased slowly but did not reach the recommended individual animal cut-
off in three of the four herds. The highest estimated ODC% was not reached until the calf was 110–130 days old.
The MilA ELISA response rose above the recommended cut-off (135 antibody units (AU)) in almost all calves, and in
two herds, the estimated mean was above the individual animal cut-off shortly after the birth of the calf. The
highest estimated antibody concentration was reached when the calf was approximately 60 days old. Disease
status of the calf was not significantly associated with the results of either test.
Conclusions: We conclude that the BioX ELISA cannot be recommended for use in calves below 3 months of age.
The MilA ELISA was able to detect antibodies shortly after birth (i.e. from approximately 3 weeks of age and
onwards) and is therefore a more sensitive test for M. bovis exposure in young calves. Neither ELISA seemed able to
differentiate between calves with arthritis and/or otitis media, and respiratory disease.
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Background
Mycoplasma bovis causes severe disease in cattle worldwide.
The typical clinical manifestations in calves are pneumonia,
otitis media and arthritis [1]. The primary diagnostic tool
used in calves is bacterial culture of body fluid samples [2],
but this is too expensive and time-consuming for use in
group or herd diagnostics or for surveillance purposes. Al-
though bacterial DNA-detection tests (such as PCR assays)
are becoming more popular, the diagnostic material used for
this technique is more difficult to obtain and process than a
blood sample. An ELISA for antibody-detection is easy to
perform on serum samples and is often less expensive, and
these assays are already commonly used for the diagnosis of
other diseases in cattle. Knowledge about the dynamics of
antibody response in infected animals in relation to disease
and age is essential when using an ELISA as a diagnostic
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tool. This knowledge requires longitudinal studies of natur-
ally exposed calves, involving repeated observations of clin-
ical signs combined with samples being taken for laboratory
testing. However, this is time-consuming, inconvenient and
expensive, and therefore rarely implemented, meaning that
our existing knowledge about antibody dynamics in calves
comes mostly from experimental studies. Calves vaccinated
with an experimental aerosol vaccine against M. bovis at
three to 4 weeks and five to 6 months of age appeared to
have a detectable immunoglobulin G (IgG) response against
M. bovis within 14 days, and the antibody concentrations in
serum remained at a high level for at least 42 and 30 days,
respectively [3].
However, neither the M. bovis antibody response to
systemic disease syndromes, such as arthritis, or the
dynamics of the antibody response over time in nat-
urally infected calves is clear. It is also crucial to
know how to interpret ELISA results in young calves,
since maternally derived antibodies against M. bovis
might be present in uninfected calves. Furthermore,
very young calves may not be able to generate an
antibody response to bacterial infections [4]. Other
authors have found the antibody titres in young dairy
calves to be low, suggesting low levels of passive
transfer of antibodies from the dam [5, 6]. No correl-
ation has yet been found between clinical signs and
antibody response in individual calves, but serocon-
version to M. bovis has been shown to be predictive
of disease at a group level in feedlot cattle [7, 8]. To
date, there have been few evaluations of the use and
interpretation of different M. bovis ELISA tests under
field conditions. A recent study found that the anti-
body response in cows was very dynamic, of short
duration and dependent on clinical signs in the cow
[9], but similar studies in calves under different herd
and disease conditions are lacking.
An in-house IgG-detection ELISA (MilA ELISA) devel-
oped by Wawegama et al. [10] has an estimated animal-level
sensitivity and specificity of 94.3% and 94.4%, respectively
using a cut-off of 105 antibody units (AU) [8]. This study
compared the results from the MilA IgG ELISA with those
obtained from the BioX K302 and K260 ELISA assays in
two small groups of experimentally infected calves, and
found that both BioX tests had low sensitivity.
To the best of our knowledge, there has been no com-
parison of the antibody responses measured using the
MilA ELISA and the BioX K302 ELISA (BioX) in dairy
calves, and knowledge about the generation of antibodies
in serum in naturally exposed calves with and without
different clinical signs is lacking. Therefore, the objective
of this longitudinal field study was to describe and com-
pare the dynamics of antibody responses to M. bovis in
the serum of dairy calves with different disease manifes-
tations using two different ELISA tests.
Methods
Data for this study were collected from four dairy herds,
from which both cows and calves were sampled. A de-
scription and an analysis of the data from cows are pre-
sented in Petersen et al. [9], while analyses of the data
from calves are presented here. The basic study design
and herd selection were the same for the two studies.
All farm owners were informed about the procedures in
the study and gave written consent to use of their ani-
mals and farm data before study start. The study design
was approved by the veterinary department of the agri-
cultural advisory services, SEGES, before initiation.
Study design
A longitudinal observational study was carried out be-
tween 1st July 2015 and 5th April 2016 in four Da-
nish dairy cattle herds with acute outbreaks of M.
bovis-associated disease. Each herd was visited five
times with an interval of approximately 3 weeks be-
tween each visit. The first visit was as close as pos-
sible to the onset of the disease outbreak. The clinical
status of selected calves was assessed at each visit,
and blood samples were collected from them. Where
possible, the same animals were sampled again at
each subsequent visit, allowing both between- and
within-animal analysis over time.
Study population
The study herds were selected based on the detection
of M. bovis-associated clinical signs by the herd advis-
ory veterinarian and by diagnostic test results (posi-
tive in PCR assays on milk samples or in ELISA tests
on sera from cows or calves). All herds had a recent
history of sudden-onset of clinical signs indicative of
M. bovis infection among the cows and/or calves, and
several strongly positive ELISA and/or PCR test re-
sults for M. bovis.
All herds tested positive in both an ELISA and a PCR
assay on at least one occasion during the study period,
but the clinical signs present in the herds and the af-
fected age groups differed. Information about the farms
is presented in Table 1.
Laboratory analysis of calves that were euthanised and
necropsied outside the planned project activities re-
vealed additional information about the study herds.
One four-month-old calf from Herd 2 had chronic de-
generative arthrosis in several joints and bronchopneu-
monia with overlying pleuritis; M. bovis was cultured
from joint fluid, and both joint fluid and lung tissue
were PCR positive for M. bovis. Two one-month-old
calves in Herd 4 had chronic omphalitis, bronchopneu-
monia, synovitis in several joints and bilateral otitis
media; Mycoplasma spp. were cultured from these calves
and identified as M. bovis by PCR.
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Bacterial culture was negative for two seven-month-old
calves from Herd 3 that were necropsied, even though
arthritis and otitis media were observed in both animals.
However, the presence of typical clinical signs (including
arthritis/swelling of the limbs, and very high serum anti-
body titres against M. bovis) in multiple cows, and the fail-
ure to detect any other pathogens suggest that it is highly
likely that the clinical signs were associated with M. bovis.
No animals from Herd 1 were necropsied, but positive
PCR results from milk from cows with mastitis were ob-
tained before and during the study period.
Sample collection
The project budget allowed for approximately 400 tests
in total, corresponding to five tests on each of 80 calves.
However, during an outbreak of M. bovis some calves
may die or be euthanized because of clinical disease, so
we initially enrolled more than 80 calves in the study.
During the first visit, the investigating veterinarian and
the farmer sampled the calves strategically to ensure that
a sufficient number of calves suspected to have M. bovi-
s-associated disease were included, as well as a sample of
calves without evidence of clinical disease. The rationale
behind this non-random sampling strategy was to
maximize the likelihood of including sufficient numbers
of animals with and without different clinical signs.
During the herd visits, each calf underwent a clinical
examination with a focus on the respiratory and
musculoskeletal system, using a standardised clinical
protocol, which is available from the corresponding au-
thor. One of three veterinarians performed the clinical
examinations, and at least one of the authors of the clin-
ical examination protocol was present at each visit.
In addition, a venous blood sample was collected from
each calf using a 10 ml plain Vacutainer tube (Kruuse,
Denmark). Blood samples were stored in a cool environ-
ment and delivered to the Eurofins Steins laboratory
(Vejen, Denmark) within 36 h of collection. The serum
samples were frozen at − 18 °C.
Detection of antibodies
The serum samples were thawed at the National Veter-
inary Institute, in the Technical University of Denmark
(DTU), Copenhagen, and analysed for antibodies against
M. bovis using the commercial kit BioX Bio K 302
ELISA (BioX Diagnostics, Rochefort, Belgium) and the
in-house indirect IgG ELISA test (MilA ELISA) devel-
oped at the University of Melbourne, Australia, by
Wawegama et al. [10].
The BioX assay was performed according to the manufac-
turer’s instructions. The test outcome was calculated as:
ODC% = ((ODsample – ODnegative control) / (ODpositive
control – ODnegative control)) × 100.
Where OD is the optical density. An ODC% > 37 was
considered positive, as recommended by the manufac-
turer. The manufacturer reported the sensitivity and
Table 1 Summary description of the four Danish dairy herds and diagnostic test results prior to and during the study period
Herd no. 1 2 3 4
Prior to enrolment
Herd size (No. of cows) 177 174 182 391
Estimated start of outbreak Early Jun 2015 Early Jul 2015 Late Nov 2015 Mid Dec 2015
After enrolment
Data collection 1 Jul 2015–16
Sep 2016
20 Jul 2015–6
Oct 2015
8 Dec 2015–23
Feb 2016
20 Jan 2016–5
Apr 2016
Age group primarily affected Cows Cows and calves Cows Cows and calves
Primary clinical signs
Cows Mastitis Mastitis, arthritis Arthritis Mastitis, arthritis
Calves Pneumonia, otitis
media
Arthritis, otitis media,
pneumonia
Few cases of arthritis
and otitis media
Arthritis, otitis media,
pneumonia
Diagnostic tests
Number of calves 15 22 20 26
Number of samples 51 101 89 93
Positive samplesa
BioXb 16 26 14 13
MilAc 48 98 41 88
Positive cultures from necropsied
calves (total necropsied calves)
0 (0) 1 (1) 0 (2) 2 (2)
aNumber of seropositive samples out of all sera obtained during the study period
bODC% values > 37 in BioX Bio K 302 ELISA (BioX Diagnostics, Belgium)
cAU > 135 in the MilA ELISA
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specificity of the test at this cut-off to be 100% in a small
sample of experimentally infected and negative control
calves [11]. However, other authors have found that the
assay has a low sensitivity in experimentally infected ani-
mals [12] and studies in cows under field conditions has
supported this observation [9].
The MilA ELISA was performed as described by
Wawegama et al. [10]. The mean antibody concentration
in antibody units (AU) was calculated by plotting the
OD values on a standard curve derived from a set of
known positive-control sera included on each plate. In
feedlot cattle with BRD the sensitivity and specificity of
this assay have been estimated at 94.3% (95% confidence
interval: 89.9–99.6%) and 94.4% (95% confidence inter-
val: 90.3–99.6%), respectively, using 105 AU as cut-off
[8]. However, the authors recommend using AU > 135 as
cut-off for a test positive interpretation.
Statistical analysis
Individual calves were categorised into the following dis-
ease groups:
1) Likely M. bovis-associated disease (‘M. bovis’).
2) Respiratory disease only (‘Respiratory’).
3) No clinical signs of disease (‘Healthy’).
This classification was based on the recorded clinical
signs and photographs of each calf taken during the herd
visits, using the following specific inclusion criteria:
 M. bovis: calves with clinical signs indicating
infection with M. bovis. All calves in this group had
arthritis and/or otitis media at one or more herd
visits, and some of these calves also had signs of
respiratory disease.
 Respiratory: calves with only clinical signs of
respiratory disease that did not fall into the category
given above. All calves had one or more of the
following clinical signs at one or more herd visits:
dyspnoea, abnormal lung sounds on auscultation,
discharge from the nares or eyes and coughing.
 Healthy: calves with no clinical signs of disease.
Modelling of antibody responses
Separate linear mixed models were used, with BioX and
MilA ELISA results as the outcome variables. The ODC%
and AU measurements were log transformed to improve
the normality of the residuals, and a fixed constant of 1
was added to all results to enable log transformation of all
values, including the small number of zero values.
For each of the two outcomes, model selection was
used to find the most parsimonious model based on the
potential explanatory variables and their two-way inter-
actions. The fixed effects to be tested were: the disease
group (categorical variable), the herd (categorical vari-
able) and the age (in days) of the calf on the sampling
date (pseudo-continuous variable). An additional quad-
ratic effect of age was included in order to allow for a
non-linear relationship between age and ELISA re-
sponse. The final model was obtained using backward
stepwise elimination based on Akaike’s information cri-
terion (AIC). A random effect of calf identification num-
ber was included in all models in order to account for
repeated samples from the same calf. Confidence inter-
vals for the predicted mean ODC% and AU values (for
an “average” calf ) were calculated for each herd using
parametric bootstrapping.
Age intervals containing fewer than three observations
from different calves in the same herd were removed.
This was done because different age groups were sam-
pled across the different herds, and to restrict the
models to regions of parameter space with enough ob-
servations. As a result, herd-specific graphs of predicted
ELISA responses span different age intervals for each
herd. Dashed vertical lines in Figs. 1 and 2 illustrate the
herd-specific age ranges included in the modelling.
The goodness of fit of the model was estimated using
marginal and conditional pseudo R2 for mixed models,
which was estimated using the method described by
Nakagawa and Schielzeth [13]. Using this method, the
marginal R2 describes the variation explained by the
fixed effects alone, and the conditional R2 describes the
variation explained by both fixed and random effects. All
data management and analyses were done in R version
3.2.2 (R Core Team, 2016), with linear mixed models im-
plemented using the lme4 package [14].
Results
Descriptive statistics
In total, 83 calves were enrolled in the study and 334
blood samples were collected. Table 2 shows the number
of calves stratified by herd and disease group.
Of the 83 calves, 52 were sampled on five occasions,
16 on four occasions, 1 on three occasions, 6 on two oc-
casions and 8 on one occasion. The primary reason for
calves dropping out of the study was euthanasia (N =
13), and eight calves were moved to another property
during the study.
Due to a laboratory error, samples from the first visit
to Herd 1 were not analysed.
The BioX ELISA response was below the recom-
mended cut-off of 37 ODC% for the entire study period
for 48 of the calves, above the cut-off for the entire study
period for eight calves, and 27 changed status (Fig. 1).
Very few calves had an ODC% above the cut-off before
they were 40–60 days old (Fig. 1).
The MilA ELISA response was above the recom-
mended cut-off of 135 AU throughout the entire study
period for the majority of the calves (Fig. 2). Only one
calf was below the cut-off at the end of the study period.
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Fig. 1 Distribution of ELISA measurements in the BioX ELISA Bio K302 assay (ODC% = sample coefficient) of serum antibodies against M. bovis in
four Danish dairy herds. Grey squares = “M. bovis”; black circles = “Respiratory”; grey dots = “Healthy”. Horizontal dashed lines show the
recommended ELISA cut-off (37 ODC%). Vertical dotted lines indicate the limits for including observations in the modelling of antibody response
dynamics. Results from the same calf are linked by lines
Fig. 2 Distribution of serum ELISA measurements in the MilA assay (AU = sample antibody units) of serum antibodies against M. bovis in four
Danish dairy herds. Grey squares = “M. bovis”; black circles = “Respiratory”; grey dots = “Healthy”. Horizontal dashed lines show the recommended
ELISA cut-off (135 AU). Vertical dotted lines indicate the limits for including observations in the modelling of antibody response dynamics. Results
from the same calf are linked by lines
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The MilA ELISA detected antibodies soon after birth
(i.e. at approximately 20 days of age), but as was evident
in Herd 3, the antibodies did not increase quickly in all
herds. The responses varied, but remained above the
cut-off once it had been reached.
Based on the raw data plots, there seems to be no as-
sociation between disease group and antibody responses
for either ELISA test (Figs. 1 and 2), so disease group
was not included as an explanatory variable in the statis-
tical models.
Modelling of antibody responses
The final model with log transformed BioX ODC% as
the outcome included the linear and quadratic effects
of age, the fixed effect of herd, and the two-way in-
teractions between herd and both the linear & quad-
ratic effects of age (Table 3). The variance associated
with the random effect of animal was considerable,
although less so than the residual variance. There
was a positive linear effect of age in all herds, but
the sign of the quadratic effect was dependent on
herd. Based on Fig. 3, the mean estimate of ODC%
in three of the four herds increased gradually with
age and did not reach the recommended individual
animal cut-off. In the remaining herd, the rate of in-
crease in ODC% increased with the age of the calf.
Table 2 Distribution of calves by disease group and herd in
a Danish longitudinal field study of four dairy herds with an
outbreak of M. bovis-associated disease
Disease group M. bovis Respiratory Healthy Total
Herd 1
Calves 2 13 0 15
Samples 8 43 0 51
Herd 2
Calves 7 14 1 22
Samples 29 70 2 101
Herd 3
Calves 6 11 3 20
Samples 23 51 15 89
Herd 4
Calves 15 10 1 26
Samples 49 40 4 93
Total
Calves 30 48 5 83
Samples 109 204 21 334
Table 3 Final model describing explanatory variables and random effects of log transformed BioX ELISA optical density measurements
(ODC%). The marginal R2 was 39% and conditional R2 was 61%
Variables Variance 95% confidence interval
Random effects
Animal 0.28 0.13–0.38
Residuals 0.47 0.37–0.54
Estimate SE p-value
Fixed effects
Intercept 2.55 0.26 < 0.001
Age days (linear) 14.68 3.93 < 0.001
Age days (quadratic) −8.16 2.27 < 0.001
Herd 1 0 –
Herd 2 0.30 0.30 0.311
Herd 3 −0.10 0.30 0.753
Herd 4 0.37 0.31 0.229
Age days (linear)*Herd 1 0 –
Age days (linear)*Herd 2 −5.93 4.27 0.165
Age days (linear)*Herd 3 7.11 4.59 0.123
Age days (linear)*Herd 4 −8.15 5.06 0.108
Age days (quadratic)*Herd 1 0 –
Age days (quadratic)*Herd 2 4.80 2.65 0.072
Age days (quadratic)*Herd 3 13.42 3.19 < 0.001
Age days (quadratic)*Herd 4 13.95 3.31 < 0.001
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The highest mean estimate of ODC% was not
reached until the calf was approximately 110–130 days
old (depending on the herd), with some suggestion of
a plateau and eventual decline above this age in three
of the herds (Fig. 3). However, a comparison of this
relationship among herds is complicated by the diffi-
culty in extrapolating the polynomial effect of age
outside the observed parameter space, which was fur-
ther compounded by the small differences in the ages
of the calves among herds.
The final model with log transformed MilA AU as
the outcome also included the linear and quadratic ef-
fects of age, the fixed effect of herd, and the two-way
interactions between herd and both the linear & quad-
ratic effects of age (Table 4). The variance associated
with the random effect of animal was less than that es-
timated for the BioX ELISA. Again, there was a positive
linear effect of age in all herds, but as for the BioX
ELISA, the sign of the quadratic effect was dependent
on herd. Based on Fig. 4, it appears that the MilA
ELISA detected antibodies in younger calves, and for
two herds, the mean estimate of MilA AU was above
the recommended animal cut-off value for animals less
than 20 days old. The overall shape of the relationship
between age and estimated AU was similar in three of
the four herds (Fig. 4). It can be characterised by an ini-
tial phase of increase followed by a plateau and an
eventual decrease, although the peak was reached at
the older age of 110–120 days in Herd 1, compared to
approximately 60–80 days in Herds 2 and 4. A signifi-
cantly different pattern, which was more similar to an
exponential increase from an initially low MilA AU
value, was estimated for Herd 3 (Fig. 4).
Discussion
This is the first observational study to illustrate and ana-
lyse the dynamics of serum antibody responses against
M. bovis in naturally exposed and infected calves. In
addition to a large variation in antibody responses
among calves both within and between herds, the key
findings were that the BioX ELISA rarely detected anti-
bodies in calves under the age of 2 months, while the
MilA ELISA was able to detect antibodies in the same
calves soon after birth. Since the calves in these herds
were all very likely to be truly exposed, we conclude that
the MilA ELISA is a potentially useful test of M. bovis
exposure. However, neither ELISA could differentiate be-
tween calves with arthritis and/or otitis, and respiratory
disease, which indicates that the tests may be less useful
for distinguishing animals with M. bovis-related diseases
from those that have just been exposed to the pathogen.
Antibody dynamics measured by the BioX ELISA
In general, very few calves seroconverted to values above
the recommended cut-off of 37 ODC%, and the majority
remained below the cut-off for the BioX ELISA for the
entire study period, despite the fact that these calves ei-
ther showed signs of M. bovis-associated disease or were
housed with diseased calves during acute outbreaks of
disease caused by M. bovis. In Herd 2, several calves had
severe arthritis, and M. bovis was cultured from one
necropsied calf. Despite this, the BioX ELISA did not de-
tect antibodies above the recommended cut-off in sera
from these calves (Fig. 1; grey triangles). It is possible
that because these calves were very young when they
were infected, their immune system was not yet able to
produce antibodies against the M. bovis antigen used in
Fig. 3 Estimated mean antibody response in sera (solid line) and 95% confidence intervals (shaded area) as measured by the BioX ELISA Bio K302
assay for the herd-specific age ranges for which observations were available. Herd 1 is grey, Herd 2 is black, Herd 3 is blue and Herd 4 is green.
The dashed line shows the recommended individual animal ELISA cut-off (37 ODC%)
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the BioX ELISA. A similar phenomenon has been seen
with Salmonella Dublin [4] and Virtala et al. [5] also
found that young calves often fail to seroconvert to com-
mon respiratory pathogens including M. bovis, although
this was assessed using a different assay. The BioX
ELISA was also used in a vaccine challenge study by
Dudek et al. [15]. In the positive control group, which
consisted of five- to six-week-old heifers intratracheally
challenged with M. bovis, the antibody response in-
creased only slightly to a maximum of approximately 50
Fig. 4 Estimated mean antibody response in serum (solid line) and 95% confidence intervals (shaded area) as measured by the in-house MilA
ELISA for the herd-specific age ranges for which observations were available. Herd 1 is grey, Herd 2 is black, Herd 3 is blue and Herd 4 is green.
The dashed line shows the recommended individual animal ELISA cut-off (135 AU)
Table 4 Final model describing explanatory variables and random effects of log transformed MilA ELISA antibody units (AU). The
marginal R2 was 59% and conditional R2 was 65%
Variables Variance 95% confidence interval
Random effect
Animal 0.09 0.007–0.150
Residuals 0.57 0.463–0.655
Estimate SE P-value
Fixed effects
Intercept 5.77 0.22 < 0.001
Age days (linear) 12.91 3.53 < 0.001
Age days (quadratic) −8.25 2.18 < 0.001
Herd 1 0 –
Herd 2 0.61 0.25 0.015
Herd 3 −0.83 0.25 0.001
Herd 4 0.32 0.26 0.231
Age days (linear)*Herd 1 0 –
Age days (linear)*Herd 2 −11.90 3.89 0.003
Age days (linear)*Herd 3 10.79 4.35 0.014
Age days (linear)*Herd 4 −15.88 4.84 0.001
Age days (quadratic)*Herd 1 0 –
Age days (quadratic)*Herd 2 4.13 2.64 0.118
Age days (quadratic)*Herd 3 14.71 3.29 < 0.001
Age days (quadratic)*Herd 4 −2.19 3.40 0.520
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ODC% at 4 weeks after challenge, and thereafter de-
clined slightly. By contrast, in the vaccinated group,
which was inoculated subcutaneously with inactivated
M. bovis mixed with two adjuvants, serum antibody con-
centrations rapidly increased within 2 weeks of vaccin-
ation and reached a maximum of around 200 ODC% in
4 weeks. This difference is likely to reflect the greater
stimulation of the systemic immune response following
inoculation with an adjuvanted whole cell vaccine com-
pared to natural infection.
Our study is the first to evaluate the dynamics of anti-
body responses as measured by the BioX ELISA in calves
under field conditions and we have shown that it is not
a suitable test for reliable diagnosis of M. bovis in calves
under 3 months of age. However, this does not exclude
the possibility that this test may be useful for group
diagnostics in younger calves with an adjusted cut-off.
Additional studies are needed to explore this possibility
in herds with differing disease status.
Antibody dynamics measured by MilA ELISA
The MilA ELISA detected antibodies above the cut-off in
calves as young as approximately 20 days of age, with anti-
body concentrations rising markedly over a short time-
frame, and at the end of the study period, all but one of
the calves were above the cut-off. However, the MilA
ELISA did not detect antibodies early in all four herds. In
Herd 3, the antibody levels did not start to rise until the
calves were 60–80 days of age, and then increased rapidly.
No M. bovis-associated disease was found among the
calves in this herd during the first two herd visits, indicat-
ing that they had managed to prevent transmission be-
tween cows and calves and had kept the infection pressure
low around the calves. In addition, the first visit to Herd 3
was only 1 week after the appearance of clinical signs in
the herd, and the farmer did not feed any waste milk to
the calves. The later response detected by the MilA ELISA
in this herd could be a result of initial infection among the
cows and later transmission to the calves (i.e. around 40–
60 days after the outbreak had started). The other herds
were visited three to 4 weeks after the outbreak had
started, and transmission to the calves had already oc-
curred by this time. This could explain the high serum
antibody concentrations in young calves in these herds. It
can therefore be concluded that the MilA assay does not
detect young calves as positive in non-infected groups of
calves, which supports a reasonable specificity and there-
fore the usefulness of this test for confirmation and sur-
veillance purposes. To substantiate this finding, control
herds with no known M. bovis-associated diseases should
be assessed for comparison. The high antibody concentra-
tions detected in most calves in this study, including the
healthy calves, suggests that the MilA test is very sensitive
and probably detects exposure to M. bovis rather than M.
bovis-associated disease. Both experimental and field stud-
ies of the MilA ELISA also suggest that this test has a high
level of sensitivity [8].
The use of antibodies to detect infection with M. bovis
Our study has shown that the M. bovis BioX and MilA ELI-
SAs give very different results for calves with the same ex-
posure and disease status in calves younger than 2 months
old indicating different immune reactions to the underlying
infection (Herd 2 and 4 in Figs. 1 and 2). In herds with clin-
ical signs in older calves, the modelled antibody responses
were similar in shape, indicating similar immune reactions
to the underlying infection (Herd 1 and 3 in Figs. 1 and 2).
This is likely associated with the age-related development
of immune competence in the calves, which is important
for the interpretation of the test results for diagnosis.
In addition to the disease burdens in the calves studied
here, severe clinical signs associated with infection with
M. bovis where found among the cows in all four herds,
which is highly likely to have resulted in transmission to
the calves in some of the herds. Fewer calves had severe
signs of M. bovis-associated disease in Herds 1 and 3 than
in Herds 2 and 4, i.e. herds with little or no segregation of
cows and calves and feeding of unpasteurised whole milk
to the calves. As M. bovis spreads by direct contact be-
tween animals and through ingestion of milk contami-
nated with M. bovis [1], this is likely to have contributed
to the severity of the disease in these two herds. In Herds
1 and 3 the calves were fed milk replacer and housed in a
building that physically separated them from the cows.
Clinical disease did not seem to correlate with the anti-
body response detected by either ELISA assay. The effect
of “Herd” was retained during model selection, indicating
that the different ELISA responses were mostly influenced
by differences among the herds, and not differences in the
underlying disease status of individual animals. Although
Martin et al. [7] performed their study using an indirect
haemagglutination assay, they also concluded that serum
antibodies against M. bovis were not indicative of disease
at an individual level, only at group level.
Only five calves were classified as being healthy, which
is a small number to include in the models as a separate
group, yet disease group was not found to be significant.
To assess the robustness of the results, models were
generated both without the ‘Healthy’ group, and with the
healthy calves included in the ‘Respiratory’ group, and
none of these variations altered the conclusions.
The ‘Respiratory’ group consisted of many calves, and it
is not possible to know whether the disease in this group
was caused by M. bovis alone or in conjunction with other
respiratory pathogens. At the time of sampling, the calves
were housed in herds with an active or recent spread of
M. bovis, so it is likely that the disease seen was at least
partly attributable to infection with M. bovis. In Herds 2
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and 4, M. bovis was isolated from necropsied calves, and
all herds were free of the likely differential diagnosis
Salmonella Dublin throughout the study period, making it
likely that the arthritis was caused by M. bovis.
Conclusions
This is the first study to evaluate the dynamics of antibody
responses using the BioX ELISA in calves under field con-
ditions. Based on our data, we cannot recommend the use
of this test in calves under 3 months of age. The MilA
ELISA was able to detect antibodies shortly after birth (i.e.
from approximately 3 weeks of age and onwards) and is
likely to be a good assay for detecting exposure to M.
bovis. Neither ELISA could differentiate between calves
with arthritis and/or otitis media, and respiratory disease.
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